Raj Desai

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Cardiovascular Events

Systematic Review

Patients Undergoing

Angiotensin Converting Enzyme

Top Venues

Clinical drug investigation

Clinical pharmacology and therapeutics

Hypertension (Dallas, Tex. : 1979)

Pharmacotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Raj Desai, Ikenna Unigwe, Munaza Riaz, Steven M Smith, Ashutosh M Shukla, Rajesh Mohandas, Nakyung Jeon, Haesuk Park
Comparative Safety of Long-Acting vs. Short-Acting Erythropoiesis-Stimulating Agents Among Patients Undergoing Hemodialysis. Clinical pharmacology and therapeutics (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Raj Desai, Ikenna Unigwe, Munaza Riaz, Steven M Smith, Ashutosh M Shukla, Rajesh Mohandas, Nakyung Jeon, Haesuk Park
Comparative Safety of Long-Acting vs. Short-Acting Erythropoiesis-Stimulating Agents Among Patients Undergoing Hemodialysis. Clinical pharmacology and therapeutics (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Christopher F Bell, Priyanka Jain, Raj Desai, Daniel C Gibbons, Myriam Drysdale, Maral DerSarkissian, Vishal Patel, Helen J Birch, Emily J Lloyd, Adina Zhang, Mei Sheng Duh, null null
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C). Clinical drug investigation 44 (3) (2024)
Raj Desai, Ikenna Unigwe, Munaza Riaz, Steven M Smith, Ashutosh M Shukla, Rajesh Mohandas, Nakyung Jeon, Haesuk Park
Comparative Safety of Long-Acting vs. Short-Acting Erythropoiesis-Stimulating Agents Among Patients Undergoing Hemodialysis. Clinical pharmacology and therapeutics 116 (1) (2024)
Raj Desai, Ikenna Unigwe, Munaza Riaz, Steven M Smith, Ashutosh M Shukla, Rajesh Mohandas, Nakyung Jeon, Haesuk Park
Comparative Safety of Long-Acting vs. Short-Acting Erythropoiesis-Stimulating Agents Among Patients Undergoing Hemodialysis. Clinical pharmacology and therapeutics 116 (1) (2024)
Raj Desai, Haesuk Park, Joshua D Brown, Rajesh Mohandas, Carl J Pepine, Steven M Smith
Comparative Safety and Effectiveness of Aldosterone Antagonists Versus Beta-Blockers as Fourth Agents in Patients With Apparent Resistant Hypertension. Hypertension (Dallas, Tex. : 1979) 79 (10) (2022)
Raj Desai, Haesuk Park, Joshua D Brown, Rajesh Mohandas, Steven M Smith
Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression. Pharmacotherapy 42 (6) (2022)